HROW vs OKE · rev $199.6M vs P/E 15, rev $21.70B
Harrow Health Inc (HROW) versus ONEOK Inc (OKE) — a side-by-side from cached financials, not a winner call.
Harrow Health Inc (HROW) is a drug manufacturers - specialty & generic company listed on US.
ONEOK Inc (OKE) is a oil & gas midstream company listed on NYSE.
Latest reported HROW revenue for 2024-12-31 was $199.6M. Net income was -$17.5M. Revenue was up 53.3% from 2023-12-31 to 2024-12-31. HROW currently screens at market cap $1.28B.
Latest reported OKE revenue for 2024-12-31 was $21.70B. Net income was $3.11B. Revenue was up 22.7% from 2023-12-31 to 2024-12-31. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
HROW currently screens at market cap $1.28B. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
Not investment advice. Open the HROW and OKE stock pages for the full models.
Not investment advice.